Sonoma Pharmaceuticals Engages Maxim Group LLC to Explore Strategic Opportunities for its U.S. Dermatology Division Jan 23, 2020
Sonoma Pharmaceuticals Announces Closing of $1.6 Million Public Offering of Common Stock Nov 29, 2019
Sonoma Pharmaceuticals Announces Pricing of Approximately $1.6 million Public Offering of Common Stock Nov 26, 2019
